Pfizer Inc PFE

Alternate Symbol(s): N.PFE

Healthcare Biotechnology

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.

NYSE:PFE - Post by User

Pfizer Inc

<< Previous

Bullboard Posts

Next >>

Post by ecolo101on Dec 19, 2024 3:26pm

43 Views

Post# 36370936

It will come back up

Quickly after year end selling for tax reason finish. Don't Forget financial people want to make their annual bonus on performance before December 31st.
We could see a fast rally. There is a few opportunities in the market with this week crash.

oil sector will also become attractive beginning of January.

also some commodities are over beaten.

happy Holidays

glta

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks